Th1/Th17 polarization and acquisition of an arthritogenic phenotype in arthritis-susceptible BALB/c, but not in MHC-matched, arthritis-resistant DBA/2 mice-Reference-Cited by-同舟云学术

Th1/Th17 polarization and acquisition of an arthritogenic phenotype in arthritis-susceptible BALB/c, but not in MHC-matched, arthritis-resistant DBA/2 mice

Published:2009-03-02 Issue:5 Volume:21 Page:511-522
ISSN:1460-2377
Container-title:International Immunology
language:en
Short-container-title:

Author:

Boldizsar Ferenc,Tarjanyi Oktavia,Nemeth Peter,Mikecz Katalin,Glant Tibor T.

Publisher

Oxford University Press (OUP)

Subject

Immunology,General Medicine,Immunology and Allergy

Link

http://academic.oup.com/intimm/article-pdf/21/5/511/17413612/dxp018.pdf

Reference52 articles.

1. Proteoglycan-induced arthritis in BALB/c mice. Clinical features and histopathology;Glant;Arthritis Rheum.,1987

2. Proteoglycan-induced arthritis: immune regulation, cellular mechanisms and genetics;Glant;Crit. Rev. Immunol.,2003

3. T-cell recognition of differentially tolerated epitopes of cartilage proteoglycan aggrecan in arthritis;Buzas;Cell. Immunol.,2005

4. Critical role of glycosaminoglycan side chains of cartilage proteoglycan (aggrecan) in antigen recognition and presentation;Glant;J. Immunol.,1998

5. Proteoglycan-induced polyarthritis and spondylitis adoptively transferred to naive (nonimmunized) BALB/c mice;Mikecz;Arthritis Rheum.,1990

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recombinant Human Proteoglycan Aggrecan‐G1 Domain‐induced Arthritis (GIA) Mouse Model;Current Protocols;2024-05

2. Splenectomy at early stage of autoimmune arthritis delayed inflammatory response and reduced joint deterioration in mice;Clinical and Experimental Immunology;2024-02-13

3. NLRC4-mediated activation of CD1c+ DC contributes to perpetuation of synovitis in rheumatoid arthritis;JCI Insight;2022-11-22

4. Splenectomy modulates the immune response but does not prevent joint inflammation in a mouse model of RA;Clinical and Experimental Immunology;2022-05-16

5. IL-17A as a Potential Therapeutic Target for Patients on Peritoneal Dialysis;Biomolecules;2020-09-24